MassBio Town Hall: One Year On: How has the Life Sciences Industry Changed to Address Current and Future Global Health Crises?

March 9, 2021 11:00 AM - 11:30 AM

Webinar, click "live-stream" button to view

Add to Calendar 3/9/2021 11:00:00 AM 3/9/2021 11:30:00 AM MassBio Town Hall: One Year On: How has the Life Sciences Industry Changed to Address Current and Future Global Health Crises?

The healthcare sector has undergone a rapid transformation in the year since COVID-19 cases began surging in the United States. From the evolution of drug and vaccine development to the increased correlation between public health outcomes and the global supply chain, the life sciences have had to rapidly innovate and continuously iterate to address COVID-19’s wide ranging impact. With COVID-19 not disappearing in the short-term despite effective vaccines, what are biotech and med tech companies doing to develop new solutions that will keep people healthy and out of the hospital in the near term while preparing us for the next global health crisis?

Our March Town Hall, in partnership with MassMEDIC, will look at how the biopharma and medical technology industries responded to the COVID-19 pandemic and how they’re using what they learned over the past year to address and plan for current and future threats.

Webinar link will be emailed to participants the day before - you can also access it from the "Live Stream" tab below. This event is for members-only.

NOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.

 Webinar, click "live-stream" button to view
CEO & President | MassBio
As CEO and President of MassBio, Kendalle Burlin O’Connell leads the strategic direction for the organization and drives policy advocacy for the industry to ensure that Massachusetts life sciences companies have the best environment possible to research, develop, manufacture, and commercialize breakthrough therapies and cures for people around the world. Pursuing innovation and delivering for members are the hallmarks of Kendalle’s more than 16 years at MassBio, including the launch of several multi-year initiatives focused on realizing a diverse and equitable life sciences industry, supporting the continued growth and sustainability of the industry throughout Massachusetts, and providing resources and solutions to companies across the industry value chain. In 2023, she was the driving force behind MassBio’s launch of Bioversity, a non-profit created to develop new training pathways and create employer connections for underrepresented populations and individuals traditionally left out of the life sciences, starting with a workforce training center in Dorchester featuring industry-aligned certification and upskilling programs. Kendalle has earned wide acclaim for her leadership and is active in mentoring and professional organizations. She has earned a spot on the Boston Business Journal’s 2023 Power 50: Movement Makers list, is ranked number 33 on Boston Magazine’s 2023 list of The 150 Most Influential Bostonians, a 2022 recipient of the Cambridge Chamber of Commerce Inspire Award recognizing outstanding women leaders in the Cambridge community, a 2022 Boston power player as named by Axios, a 2021 executive fellow in the inaugural class of the Civic Action Project Collaborative, and a 2019 Boston Business Journal 40 under 40 honoree which acknowledges a leader’s impact on Massachusetts’ industries. Kendalle received her Juris Doctor from Suffolk University Law School and currently serves as a Director on the Board of The Boston Foundation and Vice Chair of the Eastern New England Board of Directors for the American Cancer Society.